Medinotec Inc. cash flow statement MDNC

Annual Quarterly

In Q2 of fiscal 2027, the quarter ended Aug 31, 2026, Medinotec Inc. generated $107,526 of cash from operations, down 91.2% from the same quarter a year earlier. It spent $46,635 on capital expenditures. That left free cash flow of $60,891.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Aug 31, 2026	Q2 FY2027 Aug 31, 2026	Q1 FY2027 May 31, 2026	Q4 FY2026 Feb 28, 2026	Q3 FY2026 Nov 30, 2025	Q2 FY2026 Aug 31, 2025	Q1 FY2026 May 31, 2025	Q4 FY2025 Feb 28, 2025	Q3 FY2025 Nov 30, 2024
Operating
Depreciation and amortization	0 +170.3%	0 +191.1%	0 +183.5%	0 +8959.1%	0 -70.5%	0 -70.4%	0 -67.7%	-0 -102.0%	0 +49.3%
Operating cash flow	0 -45.6%	0 -91.2%	-0 +76.8%	-0 -222.2%	1 +352.3%	1 +199.6%	-1 -408.4%	0 +213.5%	0 -67.4%
Investing
Capital expenditures	0	0 +96.0%	0 +566.4%	0	—	—	—	—	0 +153.0%
Investing cash flow	-0	-0 -299.3%	-0 -566.4%	0	—	—	—	—	-0 -353.5%
Financing
Financing cash flow	—	—	—	0 +100.0%	-1 -796.2%	-1 -390.1%	-0 +93.0%	-0 -118.6%	-0 +79.8%
Change in cash
Effect of exchange rate	0 +262.7%	0 -69.8%	-0 -2.6%	0 -49.9%	0 +300.9%	0 -53.3%	-0 -287.1%	0 +164.5%	-0 -1294.0%
Net change in cash	0 +165.9%	0 -77.9%	-0 +70.8%	-0 -207.2%	1 +844.3%	0 +24.2%	-1 -182.5%	0 -28.4%	-0 +48.8%
Free cash flow	0	0 -94.9%	-0 +71.7%	-0	—	—	—	—	0 -85.3%
Per share
Free cash flow per share	—	0.01	—	—	—	—	—	—	—
Ratios
Free cash flow margin	2.97%	1.90%	-8.17%	-11.51%	—	—	—	—	2.02%
Capital expenditures to revenue	0.69%	1.46%	1.52%	4.88%	—	—	—	—	2.83%
Cash conversion	0.63x	2.63x	-0.79x	—	1.40x	3.53x	-6.67x	0.07x	0.40x

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: MDNC (OTC)
Fiscal year ends: February 28
Incorporated in: NV
Headquarters: Johannesburg
SEC filer status: Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK: 1931055

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.